Author: Kathy Whitney
Aug. 1, 2013—People with the most common irregular heart rhythm known as atrial fibrillation (AF) are at greater risk for stroke due to the formation of clots in the left atrial appendage (LAA), a small pouch which empties blood into the left atrium.
Jul. 25, 2013—Benjamin Byrd III, M.D., professor of Cardiovascular Medicine, has been named president of the 16,000-member American Society of Echocardiography (ASE) for a one-year term following the society’s 24th Annual Scientific Sessions, which were held earlier this month in Minneapolis.
Jul. 18, 2013—Vanderbilt Heart and Vascular Institute physicians are taking advantage of new technology in critical care that allows them to quickly visualize the patient’s heart at the bedside.
Jul. 12, 2013—Mark Schoenfield, chair of Vanderbilt’s English department, and his family were a little behind schedule a few weeks ago as they prepared to drive to the airport. The slight delay may have saved Pastor Rob Taylor’s life.
Jul. 11, 2013—Mark Schoenfield, Ph.D., chair of Vanderbilt’s Department of English, and his family were a little behind schedule a few weeks ago as they prepared to drive from their home in Hillsboro Village to the airport.
Jun. 6, 2013—Individuals who provide annual philanthropic support for key areas at Vanderbilt University Medical Center were recognized at the Canby Robinson Society Reception on May 21.
May. 9, 2013—Peggi Angel, Ph.D., research instructor in Biochemistry, studies congenital aortic valve stenosis in children. It’s a disease where the heart valve, which is normally very thin, becomes bloated with extracellular matrix. This occurs rapidly in some children but not in others.
Apr. 25, 2013—A Vanderbilt University School of Medicine student is among 13 individuals nationwide to receive a Sarnoff Foundation Medical Student Research Fellowship award for 2013-2014.
Apr. 25, 2013—Vanderbilt Heart and Vascular Institute is participating in a clinical study to further evaluate the safety and feasibility of rapidly lowering the body’s temperature to significantly reduce the amount of damage caused by a heart attack.
Apr. 18, 2013—Thomas Wang, M.D., has joined Vanderbilt as director of the Division of Cardiovascular Medicine and the physician-in-chief of the Vanderbilt Heart and Vascular Institute.
Apr. 11, 2013—The state of Michael Stanbery’s health was shocking.
Mar. 14, 2013—Vanderbilt University Medical Center and Acorda Therapeutics Inc. released findings from a Phase 1 clinical trial of glial growth factor 2 (GGF2) last week at the American College of Cardiology Annual Scientific Session in San Francisco.